Viewing Study NCT00325819



Ignite Creation Date: 2024-05-05 @ 4:49 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00325819
Status: COMPLETED
Last Update Posted: 2017-10-13
First Post: 2006-05-11

Brief Title: Acetaminophen Before Vaccines for Infants Study AVIS
Sponsor: Kaiser Permanente
Organization: Kaiser Permanente

Study Overview

Official Title: A Randomized Placebo-controlled Trial of Acetaminophen for Prevention of Post-vaccination Fever in Infants
Status: COMPLETED
Status Verified Date: 2017-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to see whether giving acetaminophen the medicine in Tylenol for routine infant vaccinations is helpful in preventing fever or other symptoms
Detailed Description: Post-vaccination fever occurs in up to 40 of infants receiving routinely recommended childhood vaccinations Although serious events are rare post-vaccination fever causes discomfort for the child can lead to medical utilization can rarely result in febrile seizure and can cause a working parent to miss time from their job to care for a febrile infant who cannot attend day care The benefits of acetaminophen prophylaxis for infants receiving current vaccinations in terms of reduction of discomfort for the child improvement of quality-of-life indicators for the parent or reduction of medical utilization have not been measured This randomized blinded placebo-controlled trial will assess the efficacy of prophylaxis with acetaminophen in prevention of fever following routine childhood immunizations

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None